Sponsor Pipeline

Rezolute Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Phase 3
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06881992 A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism Tumor Hyperinsulinism (Tumor HI) Recruiting
NCT06208215 RZ358 Treatment for Congenital Hyperinsulinism Congenital Hyperinsulinism Active, Not Recruiting
Get alerts when Rezolute's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free